Answers are grounded in this paper and cite their sources.
Monitoring of glycemic status, as performed by patients and health care providers, is considered a cornerstone of diabetes care.Results of monitoring are used to assess the efficacy of therapy and to guide adjustments in medical nutrition therapy (MNT), exercise, and medications to achieve the best possible blood glucose control.This position statement presents the recommendations of the American Diabetes Association on the tests used most widely in monitoring the glycemic status of people with diabetes and addresses both patient and physician/laboratorybased testing.It does not address tests for diabetes screening and diagnosis.The recommendations are based on the American Diabetes Association's technical review on the subject, which should be consulted for further information (1). BLOOD GLUCOSE TESTINGBY PATIENTS -Within only a few years, self-monitoring of blood glucose (SMBG) by patients has revolutionized management of diabetes.Using SMBG, patients with diabetes can work to achieve and maintain specific glycemic goals.Given the results of the Diabetes Control and Complications Trial (DCCT) and other studies, there is broad consensus on the health benefits of normal or nearnormal blood glucose levels and on the importance, especially in insulin-treated patients, of SMBG in treatment efforts designed to achieve such glycemic goals.The subject of SMBG has been addressed extensively by two American Diabetes Association Consensus Conferences, which provide a comprehensive review of the subject (2,3).
No takes yet. Share an insight, caveat, or question.
A 2003 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: